Geode Capital Management’s Derma Sciences DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-127,650
| Closed | -$663K | – | 4152 |
|
|
2016
Q4 | $663K | Buy |
127,650
+352
| +0.3% | +$1.66K | ﹤0.01% | 3173 |
|
|
2016
Q3 | $594K | Buy |
127,298
+88
| +0.1% | +$411 | ﹤0.01% | 3186 |
|
|
2016
Q2 | $501K | Sell |
127,210
-2,487
| -2% | -$9.29K | ﹤0.01% | 3224 |
|
|
2016
Q1 | $401K | Sell |
129,697
-20,847
| -14% | -$69.8K | ﹤0.01% | 3339 |
|
|
2015
Q4 | $687K | Buy |
150,544
+23,073
| +18% | +$109K | ﹤0.01% | 3103 |
|
|
2015
Q3 | $600K | Sell |
127,471
-3,356
| -3% | -$21.7K | ﹤0.01% | 3136 |
|
|
2015
Q2 | $936K | Sell |
130,827
-4,685
| -3% | -$35.2K | ﹤0.01% | 2927 |
|
|
2015
Q1 | $1.15M | Buy |
135,512
+7,008
| +5% | +$59.7K | ﹤0.01% | 2796 |
|
|
2014
Q4 | $1.2M | Buy |
128,504
+2,608
| +2% | +$22.7K | ﹤0.01% | 2737 |
|
|
2014
Q3 | $1.05M | Buy |
125,896
+1,754
| +1% | +$16.2K | ﹤0.01% | 2749 |
|
|
2014
Q2 | $1.44M | Buy |
124,142
+2,504
| +2% | +$25.7K | ﹤0.01% | 2577 |
|
|
2014
Q1 | $1.54M | Buy |
121,638
+66,288
| +120% | +$857K | ﹤0.01% | 2500 |
|
|
2013
Q4 | $598K | Buy |
55,350
+537
| +1% | +$6.24K | ﹤0.01% | 3000 |
|
|
2013
Q3 | $679K | Buy |
54,813
+1,703
| +3% | +$23.6K | ﹤0.01% | 2799 |
|
|
2013
Q2 | $709K | Hold |
53,110
| – | – | ﹤0.01% | 2664 |
|
Other funds holding DSCI
Geode Capital Management's DSCI Position: Q1 2017 in Review
Geode Capital Management sold out of Derma Sciences (DSCI) in Q1 2017, closing a stake of 127,650 shares — an estimated $663K sold.
Geode Capital Management first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $1.54M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Geode Capital Management reported no remaining Derma Sciences position as of Q1 2017 after selling out during the quarter.
- Geode Capital Management sold 127,650 Derma Sciences shares in Q1 2017, an estimated $663K.
- Geode Capital Management first reported a position in Derma Sciences in Q2 2013 and held it in 15 quarters.
- Geode Capital Management's Derma Sciences position peaked at $1.54M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences as of Q1 2017.
Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.